Antios Therapeutics Company
Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.
Funding Status:
Early Stage Venture
Industry:
Biopharma, Biotechnology, Therapeutics
Investors Number:
16
Last Funding Date:
2021
Technology:
Cancer
Founded Date:
2018
Investor Type:
Early Stage Venture
Headquarters:
Atlanta, Georgia, United States
Total Funding:
125399999
Last Funding Type:
Series B
Employee Number:
11-50